integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
PVMBAGXWHHZKFP-JMPJWMFJSA-N
TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z))[iso3]
PVMBAGXWHHZKFP-JMPJWMFJSA-N
CHEBI:90052
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
PVMBAGXWHHZKFP-JMPJWMFJSA-N
InChI Key
PVMBAGXWHHZKFP-JMPJWMFJSA-N
IUPAC name
Preferred name
TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z))[iso3]
INN name
—
Synonym
TAG(50:4)
ChEBI
CHEBI:90052
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
Observed in differential profiles
non_COVID_19_healthy_vs_non_critical_COVID_19
Wild_Type_vs_TMAVA_Treatment